Aurinia Pharmaceuticals (AUPH) Research & Development (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Research & Development of $7.5 million for Q1 2026, down 31.44% on a QoQ basis from $10.9 million in Q4 2025, and up 30.07% year-over-year from $5.7 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Research & Development (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Research & Development history runs 7 years deep, the most recent figure standing at $7.5 million for Q1 2026.
- Quarterly Research & Development rose 30.07% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.2 million (up 63.19% YoY) and the FY2025 annual result came in at $32.5 million, up 56.39% from the prior year.
- Research & Development was $7.5 million for Q1 2026 at Aurinia Pharmaceuticals, down from $10.9 million in the prior quarter.
- Across five years, Research & Development topped out at $13.6 million in Q3 2023 and bottomed at $3.0 million in Q3 2024.
- A 5-year average of $8.6 million and a median of $8.4 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development surged 228.95% — and 2024, when it sank 77.6%.
- Aurinia Pharmaceuticals' Research & Development stood at $9.9 million in 2022, then climbed by 3.63% to $10.2 million in 2023, then fell by 20.74% to $8.1 million in 2024, then soared by 34.39% to $10.9 million in 2025, then plunged by 31.44% to $7.5 million in 2026.
- Business Quant data shows AUPH's Research & Development at $7.5 million in Q1 2026, $10.9 million in Q4 2025, and $8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Aurinia Pharmaceuticals | 2.04 Bn | 1.66 Bn | 71.20 Mn | 7.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.47 Mn |
| Dec 31, 2025 | 10.90 Mn |
| Sep 30, 2025 | 8.44 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 5.74 Mn |
| Dec 31, 2024 | 8.11 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 4.08 Mn |
| Mar 31, 2024 | 5.55 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Sep 30, 2023 | 13.61 Mn |
| Jun 30, 2023 | 12.65 Mn |
| Mar 31, 2023 | 13.16 Mn |
| Dec 31, 2022 | 9.87 Mn |
| Sep 30, 2022 | 10.97 Mn |
| Jun 30, 2022 | 11.53 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 11.15 Mn |
| Sep 30, 2021 | 20.07 Mn |
| Jun 30, 2021 | 10.09 Mn |